
Sai Yendamuri
Dr. Sai Yendamuri is a thoracic surgeon at Roswell Park Comprehensive Cancer Center in Buffalo, New York, where he specializes in the relationship between obesity and cancer. He has garnered attention for his insights on how glucagon-like peptide-1 (GLP-1) medications, commonly used for weight loss, may influence cancer risk and patient outcomes. Yendamuri emphasizes the significant connection between obesity and various cancers, advocating for further research into how weight-loss drugs could potentially enhance immune responses against cancer cells and improve survival rates among patients.
Country presence
Recent news mentions
Sai Yendamuri, M.D., a thoracic surgeon at Roswell Park Comprehensive Cancer Center in Buffalo, New York, speaks to Fox News Digital about whether weight-loss drugs could reduce cancer risk.
Obesity drugs may boost immune response to fight cancer, doctor says